Sign In
Buy AMGN
$338.22
+9.96 (+3.03%)
At Close: Jun 03, 2026
U.S. stocks end slightly lower following best month for S&P 500, Dow since November 2020
08:33pm, Monday, 01'st Aug 2022 MarketWatch
U.S. stocks end lower on Monday, snapping three straight sessions of gains.
AMGEN ANNOUNCES WEBCAST OF 2022 SECOND QUARTER FINANCIAL RESULTS
04:00pm, Monday, 01'st Aug 2022
THOUSAND OAKS, Calif. , Aug. 1, 2022 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that it will report its second quarter financial results on Thursday, August 4, 2022, after the close of the U.
Analysts Estimate Heska (HSKA) to Report a Decline in Earnings: What to Look Out for
02:01pm, Monday, 01'st Aug 2022 Zacks Investment Research
Heska (HSKA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Amgen (AMGN) to Report Q2 Earnings: What's in the Cards?
02:00pm, Monday, 01'st Aug 2022 Zacks Investment Research
Volume growth from Amgen's (AMGN) key drugs like Prolia, Xgeva, Repatha, and others is expected to have been partially offset by biosimilar/generic competition for mature drugs.
July’s Big Rally Could Continue, But Consider The Risks
09:16am, Monday, 01'st Aug 2022 Investing.com
Big Tech survived the earnings test, but many more tech companies are picking up their pencils
01:00pm, Sunday, 31'st Jul 2022 MarketWatch
Wall Street breathed a sigh of relief this week after Big Tech produced results that were largely not as bad as feared (except for Facebook), but the harder part of this earnings season may arrive in
Do These 3 New Moneymakers for AstraZeneca Make It a Buy?
12:55pm, Sunday, 31'st Jul 2022 The Motley Fool
Cranking out new medicines is business as usual, but these three could be big earners.
AbbVie's (ABBV) Q2 Earnings Beat Estimates, Revenues Lag
07:40pm, Friday, 29'th Jul 2022 Zacks Investment Research
AbbVie's earnings (ABBV) beat estimates for second-quarter 2022, while sales miss the same. ABBV's immunology and neuroscience drugs drive sales. Shares decline in pre-market trading.
10 Biggest Companies Reporting Q2 Earnings Next Week
05:12am, Friday, 29'th Jul 2022 Investing.com
Amgen (AMGN) Stock Sinks As Market Gains: What You Should Know
09:50pm, Thursday, 28'th Jul 2022 Zacks Investment Research
In the latest trading session, Amgen (AMGN) closed at $249.75, marking a -0.78% move from the previous day.
Pfizer (PFE) Q2 Earnings Top, COVID Products Drive Sales
02:39pm, Thursday, 28'th Jul 2022 Zacks Investment Research
Pfizer (PFE) beats estimates for Q2 earnings and sales. It maintains the sales forecast for COVID products, Comirnaty and Paxlovid.
Amgen (AMGN) Reports Next Week: Wall Street Expects Earnings Growth
02:02pm, Thursday, 28'th Jul 2022 Zacks Investment Research
Amgen (AMGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Healthcare ETFs in Focus Ahead of Q2 Earnings
01:14pm, Thursday, 21'st Jul 2022
The healthcare sector has gained some momentum lately on investors' rush to safety in a volatile stock market. The sector is non-cyclical in nature, which in turn, is providing a cushion to the portfo
2 Rock-Solid Dividend Stocks to Buy Right Now
09:45am, Thursday, 21'st Jul 2022
These two dividend-paying pharmaceutical titans ought to keep crushing the broader markets for the foreseeable future.
7 Best Pharmaceutical Stocks to Buy Now
06:00pm, Wednesday, 20'th Jul 2022
These investments represent the best pharmaceutical stocks. Each offers incredible upside potential in the post-pandemic world.
